Analysis of HERV-K (HML2) Expression in Colorectal Cancer Samples

Valentina S. Obrezanenko(Federal Agency for Health and Social Development), А. С. Макарова(Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency), В. В. Макаров(Lomonosov Moscow State University), V. S. Yudin(Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency), Daria Tarasova(Federal Agency for Health and Social Development), Ekaterina A. Snigir(Federal Agency for Health and Social Development), А. А. Ивашечкин(Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency), Antonida V. Makhotenko(Institute of Bioorganic Chemistry), Elizaveta I. Radion(Federal Agency for Health and Social Development), Maria S Cheporova(Ministry of Health), Ekaterina Bolashova(Federal Agency for Health and Social Development), Alexey A. Tryakin(Ministry of Health), Anastasia G. Volkova(Federal Agency for Health and Social Development), Alexandra D. Kikot(Federal Agency for Health and Social Development), Olesya A. Kuznetsova(Ministry of Health), Yulia A. Masyukova(Federal Agency for Health and Social Development), Polina M. Shulga(Federal Agency for Health and Social Development), Yulia A. Remizova(Federal Agency for Health and Social Development), Michail Y. Fedyanin(Ministry of Health), Ivan O. Meshkov(Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency), Anastasia A. Primova(Federal Agency for Health and Social Development), Anton А. Keskinov(Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency)
Epigenomes
February 12, 2026
Cited by 1


Related Papers